{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:14:00Z","timestamp":1789841640679,"version":"4.0.1"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134142","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T13:57:54Z","timestamp":1438264674000},"page":"e0134142","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":105,"title":["Therapeutic Effect of Berberine on Huntington\u2019s Disease Transgenic Mouse Model"],"prefix":"10.1371","volume":"10","author":[{"given":"Wenxiao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta A.","family":"Gaertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"C Landles","year":"2004","journal-title":"EMBO Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats","volume":"330","author":"B Kremer","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","article-title":"Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?","volume":"127","author":"F Squitieri","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"P Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"SH Li","year":"2004","journal-title":"Trends Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1M582","article-title":"Role of tetrabenazine for Huntington's disease-associated chorea","volume":"44","author":"LH Poon","year":"2010","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JHD-140107","article-title":"Tetrabenazine, depression and suicide: good news","volume":"3","author":"RL Margolis","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1254\/fpj.102.101","article-title":"Pharmacological studies on antidiarrheal effects of berberine and geranii herba","volume":"102","author":"H Takase","year":"1993","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"W Kong","year":"2004","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(99)00264-5","article-title":"Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines","volume":"148","author":"N Iizuka","year":"2000","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bmcl.2006.12.085","article-title":"Antiviral activity of berberine and related compounds against human cytomegalovirus","volume":"17","author":"K Hayashi","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"H Zhang","year":"2010","journal-title":"Metabolism"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2010.07.023","article-title":"Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway","volume":"331","author":"Q Jiang","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"591654","DOI":"10.1155\/2012\/591654","article-title":"Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis","volume":"2012","author":"H Dong","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5213\/inj.2014.18.3.115","article-title":"Inhibitory Effects of Isoquinoline Alkaloid Berberine on Ischemia-Induced Apoptosis via Activation of Phosphoinositide 3-Kinase\/Protein Kinase B Signaling Pathway","volume":"18","author":"M Kim","year":"2014","journal-title":"Int Neurourol J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2010.09.038","article-title":"Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease","volume":"486","author":"IH Kwon","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","article-title":"Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"36","author":"KS Shin","year":"2013","journal-title":"Arch Pharm Res"},{"key":"ref18","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","author":"J Lan","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1142\/S0192415X05003557","article-title":"Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract","volume":"33","author":"X Wang","year":"2005","journal-title":"Am J Chin Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2202-7-78","article-title":"Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease","volume":"7","author":"F Zhu","year":"2006","journal-title":"BMC Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/aoms.2013.33354","article-title":"Effects of berberine on beta-secretase activity in a rabbit model of Alzheimer's disease","volume":"9","author":"N Panahi","year":"2013","journal-title":"Arch Med Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2006.11.043","article-title":"Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion","volume":"352","author":"M Asai","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model","volume":"33","author":"SS Durairajan","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1083\/jcb.200710158","article-title":"Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin","volume":"181","author":"CE Wang","year":"2008","journal-title":"J Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/hmg\/ddq127","article-title":"Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments","volume":"19","author":"X Li","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijrobp.2007.08.034","article-title":"Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death","volume":"70","author":"PL Peng","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jcb.22869","article-title":"Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism","volume":"111","author":"N Wang","year":"2010","journal-title":"J Cell Biochem"},{"key":"ref28","first-page":"397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"G Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI45364","article-title":"The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease","volume":"121","author":"I Munoz-Sanjuan","year":"2011","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"P Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease","volume":"225","author":"DJ Ho","year":"2010","journal-title":"Exp Neurol"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/molecules16086732","article-title":"Berberine: a potential multipotent natural product to combat Alzheimer\u2019s disease","volume":"16","author":"HF Ji","year":"2011","journal-title":"Molecules"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2011.10.019","article-title":"Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase\/AKT and NF-E2-related factor-2 signaling pathway in astrocytes","volume":"12","author":"JH Chen","year":"2012","journal-title":"International immunopharmacology"},{"issue":"2","key":"ref35","first-page":"159","article-title":"Berberine promotes glucagon-like peptide-1 (7\u201336) amide secretion in streptozotocin-induced diabetic rats","volume":"200","author":"SS Lu","year":"2009","journal-title":"Journal of Endocrinology"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","article-title":"Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies","volume":"79","author":"Y Yu","year":"2010","journal-title":"Biochemical pharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.03.065","article-title":"Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-\u03baB expression, ameliorated BBB permeability","volume":"1459","author":"X Zhang","year":"2012","journal-title":"Brain research"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410330406","article-title":"Association of a monoamine oxidase B allele with Parkinson's disease","volume":"33","author":"JH Kurth","year":"1993","journal-title":"Annals of neurology"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-0102(02)00005-6","article-title":"Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells","volume":"42","author":"Y Lei","year":"2002","journal-title":"Neuroscience research"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","article-title":"Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?","volume":"45","author":"HE de Vries","year":"2008","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"T Perry","year":"2007","journal-title":"Experimental neurology"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Y Li","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1128\/MCB.19.8.5800","article-title":"Akt\/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria","volume":"19","author":"SG Kennedy","year":"1999","journal-title":"Molecular and cellular biology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2741\/1197","article-title":"CREB and neurodegeneration","volume":"9","author":"M Dragunow","year":"2004","journal-title":"Frontiers in bioscience: a journal and virtual library"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"EA Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Z Qiu","year":"2006","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","author":"RA Quintanilla","year":"2008","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"K Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1750-3639.2008.00258.x","article-title":"Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin","volume":"20","author":"NL Dudek","year":"2010","journal-title":"Brain Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"C Soto","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02265","article-title":"Therapeutic approaches to protein-misfolding diseases","volume":"426","author":"FE Cohen","year":"2003","journal-title":"Nature"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T14:07:26Z","timestamp":1599401246000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134142"}},"subtitle":[],"editor":[{"given":"Huaibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134142","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}